Preclinical evaluation of Hibiscus cannabinus Linn. in the treatment of urolithiasis and cholelithiasis
- Author:
Swathi Suresh
1
;
Ankul Singh S
1
;
Chitra Vellapandian
1
Author Information
1. Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603209, India
- Publication Type:Journal Article
- Keywords:
Hibiscus cannabinus Linn. (H. cannabinus), Cholelithiasis, Urolithiasis, Kenaf, Gallstone, Kidney stone
- From:
Digital Chinese Medicine
2023;6(2):189-197
- CountryChina
- Language:English
-
Abstract:
【Objective】 To investigate the therapeutic effect of Hibiscus cannabinus Linn. (H. cannabinus)
leaves on cholelithiasis and urolithiasis.
【Methods】 The study evaluated the effect of aqueous leaf extract of H. cannabinus on thiouracil
and cholesterol cholic acid diet induced cholelithiasis in BALB/c mice and ethylene glycol induced urolithiasis in Wistar rats. Three doses of aqueous extract (40, 80, and 160 mg/kg) were selected to evaluate the effectiveness in cholelithiasis in mice; another three doses of aqueous extract (400, 800, and 1 600 mg/kg) were administered for evaluating the effect on urolithiasis in rats. Biochemical parameters such as biliary cholesterol, biliary phospholipid, and bile acid were determined in cholelithiasis model. Similarly, 24-hour urine output, urinary parameters such as creatinine, uric acid, protein, urea, presence of calcium oxalate crystals, red blood cells (RBCs), and pyuria were determined in urolithiasis model.
【Results】 Statistically significant differences were noted in the biliary and urinary parameters after administrating three test doses of H. cannabinus aqueous extract (P < 0.05).
【Conclusion】 H. cannabinus was found to be effective against high fat lithogenic diet urolithiasis and cholelithiasis.
